Showing results (31-40 of 148) with videos related to
Sort By:
Pageof 15
Disability and Rehabilitation|November 23, 2007
Pharmacology of therapeutic botulinum toxin preparationsDirk Dressler, Reiner BeneckeClinical Parkinsonism & Related Disorders|February 20, 2026
Polysomnographic characteristics in patients with idiopathic dystoniaLejla Paracka, Lan Ye, Jann Lübke, et al.Journal of Neural Transmission (Vienna, Austria : 1996)|December 11, 2012
Interdisziplinärer Arbeitskreis Bewegungsstörungen (IAB): an interdisciplinary working group for promoting multimodal therapy of movement disordersFereshte Adib Saberi, Dirk DresslerJournal of Neural Transmission (Vienna, Austria : 1996)|August 1, 2020
Botulinum toxin therapy in the SARS-CoV-2 pandemic: patient perceptions from a German cohortDirk Dressler, Fereshte Adib SaberiEuropean Neurology|January 15, 2005
Botulinum toxin: mechanisms of actionDirk Dressler, Fereshte Adib SaberiJournal of Neural Transmission (Vienna, Austria : 1996)|October 18, 2016
Safety of botulinum toxin short interval therapy using incobotulinumtoxin ADirk Dressler, Fereshte Adib SaberiFrontiers in Neurology|March 22, 2018
Impaired Quality of Life and Need for Palliative Care in a German Cohort of Advanced Parkinson's Disease PatientsMartin Klietz, Amelie Tulke, Lars H Müschen, et al.Journal of Neural Transmission (Vienna, Austria : 1996)|December 21, 2013
Botulinum toxin in myotonia congenita: it does not help against rigidity and painDirk Dressler, Fereshte Adib SaberiJournal of Neural Transmission (Vienna, Austria : 1996)|August 30, 2022
Potency of botulinum toxin drugs: test systems and labellingDirk Dressler, Eric A JohnsonJournal of Neural Transmission (Vienna, Austria : 1996)|June 15, 2013
Towards a dose optimisation of botulinum toxin therapy for axillary hyperhidrosis: comparison of different Botox(®) dosesDirk Dressler, Fereshte Adib SaberiPageof 15